2020
DOI: 10.1038/s41557-019-0407-6
|View full text |Cite
|
Sign up to set email alerts
|

Merging chemoenzymatic and radical-based retrosynthetic logic for rapid and modular synthesis of oxidized meroterpenoids

Abstract: Meroterpenoids are natural products of hybrid biosynthetic origins-derived from both terpenoid and polyketide pathways-with a wealth of biological activities. Given their therapeutic potential, a general strategy to access these natural products in a concise and divergent fashion is highly desirable. Here, we report a modular synthesis of a suite of oxidized meroterpenoids using a hybrid synthetic strategy that is designed to harness the power of both biocatalytic and radicalbased retrosynthetic logic. This st… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
82
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(82 citation statements)
references
References 51 publications
0
82
0
Order By: Relevance
“…The production of the anti-cancer and antimicrobial meroterpenoids was achieved via the design of modular retrosynthetic pathways. The addition of molecular handle hydroxyl groups was achieved by variants related to 1857 (V78A/A82G/F87V/P142S/T175I/A184V/F205C/S226R/H236Q/E252G/R255S/A290V/L353V) [ 103 , 104 ]. The selective 3-hydroxylation of sclareolide, an antifungal precursor to arisugacin F and phenylpyropene C, gave an 80–90% conversion and a 60–70% yield for 1857/V328A.…”
Section: Engineering Bm3 For Drug Metabolite Productionmentioning
confidence: 99%
See 1 more Smart Citation
“…The production of the anti-cancer and antimicrobial meroterpenoids was achieved via the design of modular retrosynthetic pathways. The addition of molecular handle hydroxyl groups was achieved by variants related to 1857 (V78A/A82G/F87V/P142S/T175I/A184V/F205C/S226R/H236Q/E252G/R255S/A290V/L353V) [ 103 , 104 ]. The selective 3-hydroxylation of sclareolide, an antifungal precursor to arisugacin F and phenylpyropene C, gave an 80–90% conversion and a 60–70% yield for 1857/V328A.…”
Section: Engineering Bm3 For Drug Metabolite Productionmentioning
confidence: 99%
“…The selective 3-hydroxylation of sclareolide, an antifungal precursor to arisugacin F and phenylpyropene C, gave an 80–90% conversion and a 60–70% yield for 1857/V328A. A 62% yield was achieved by 1857/V328A/L75A for the oxidation of a tricyclic intermediate at the C3 position, forming a key intermediate for further chemical modification, ultimately yielding either chevalone or stypodiol [ 104 ].…”
Section: Engineering Bm3 For Drug Metabolite Productionmentioning
confidence: 99%
“…In early 2020, Renata's group accessed eight natural products from α-pyrone and diterpene meroterpenoids subsets in a concise, high-yielding and modular fashion. 25 While some of them [arisugacin F (160) 26 , pyripyropene E (161) 27 , taondiol (162) 28,29 , and stypodiol (163) 30 ] have been subjects of multiple synthetic studies, others [phenylpyropenes C (164) and F (165), decaturin E (166) and chevalone A (167)] were synthesized for the first time. Instead of using more conventional Wieland-Mischer ketone, sclareolide (168) and sclareol (169) were The remaining four diterpene meroterpenoids were constructed from butenolide 177, which itself was forged from sclareol (169) via peracryloylation, ring-closing metathesis with Grubbs second-generation catalyst and NaH-CO 3 mediated elimination (Scheme 18).…”
Section: Renata's Total Syntheses Of α-Pyrone and Diterpene Meroterpenoids (2020)mentioning
confidence: 99%
“…Furthermore, these enzymes exhibit high catalytic efficiencies, and typically have large turnover numbers 11 , 14 , 37 , 38 . These features of Fe/αKG oxygenases, along with their catalytic versatility, have attracted considerable attention as a source of biocatalysts 36 , 39 .…”
Section: Introductionmentioning
confidence: 99%